Sensitizing TRAIL response via differential modulation of anti- and pro-apoptotic factors by AZD5582 combined with ER nanosomal TRAIL in neuroblastoma-Reference-Cited by-同舟云学术

Sensitizing TRAIL response via differential modulation of anti- and pro-apoptotic factors by AZD5582 combined with ER nanosomal TRAIL in neuroblastoma

Published:2022-02 Issue:2 Volume:124 Page:151856
ISSN:0065-1281
Container-title:Acta Histochemica
language:en
Short-container-title:Acta Histochemica

Author:

Huang Chaohong,He Yujie,Sun Jianwu,Yuan Qian,Li Shuyi,Hou Huan,Su Kui,Ke Changhong,Du Zhiyun,Yuan Zhengqiang

Publisher

Elsevier BV

Subject

Cell Biology,Histology,General Medicine

Reference24 articles.

1. Discovery of a novel class of dimeric Smac mimetics as potent IAP antagonists resulting in a clinical candidate for the treatment of cancer (AZD5582);Hennessy;J. Med. Chem.,2013

2. TRAIL-armed ER nanosomes induce drastically enhanced apoptosis in resistant tumor in combination with the antagonist of IAPs (AZD5582);Hou;Adv. Healthc. Mater.,2021

3. Analysis of treatment cost for neuroblastoma to the family: a single-center cross-sectional study in China;Jiang;J. Med Econ.,2020

4. Extracellular vesicle delivery of TRAIL eradicates resistant tumor growth in combination with CDK inhibition by dinaciclib;Ke;Cancers (Basel),2020

5. Loss of functional BAP1 augments sensitivity to TRAIL in cancer cells;Kolluri;eLife,2018

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mesenchymal stem cell-based TRAIL delivery inhibits the metastatic state of clinical therapy-resistant progressive neuroblastoma;World Journal of Pediatrics;2023-12-07

2. Optimized lipopolymers with curcumin to enhance AZD5582 and GDC0152 activity and downregulate inhibitors of apoptosis proteins in glioblastoma multiforme;Biomaterials Advances;2023-11

3. Selective CDK9 knockdown sensitizes TRAIL response by suppression of antiapoptotic factors and NF-kappaB pathway;Apoptosis;2023-04-15